79359336 - EVOX THERAPEUTICS

Information

• Trademark
• 79359336

• Source

• Serial Number

  79359336

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 01, 2022
  2 years ago

• Transaction Date

  January 31, 2025
  14 days ago

• Status Date

  January 30, 2025
  15 days ago

• Published for Opposition Date

  January 21, 2025
  24 days ago

• Location Date

  December 30, 2024
  a month ago

• Status Code

  802

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  ALLEN, BIANCA

• Attorney Docket Number

  EVOX 2312584

  Attorney Name

  NANCY SABARRA

  Law Office Assigned Location Code

  N50

• Owners

  • Evox Therapeutics Limited

Case File Statements

• GS0051: Pharmaceuticals, namely, drug delivery agents in the form of exosomes consisting of compounds that facilitate the delivery of a wide range of pharmaceutical preparations; pharmaceutical preparations, namely, drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for therapeutic use, namely, for the release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, engineered exosomes to deliver pharmaceutical preparations in the nature of protein for genetic therapy; medicine, namely, drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; medical preparations, namely, drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; biological preparations for medical purposes, namely, for the treatment of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; biological preparations for the treatment of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, muscular dystrophy; biological preparations comprising exosomes, namely, drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations, for the treatment of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; biological preparations comprising a therapeutic target protein-loaded exosome that facilitates the delivery of pharmaceutical preparations, for the treatment of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; biological preparations comprising exosomes for pharmaceutical purposes that facilitate the delivery of pharmaceutical preparations, for the treatment of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; biological reagents for medical use, namely, drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; mixed biological preparations for medical purposes, namely, for the prevention and treatment of infectious diseases; mixed biological preparations for the prevention and treatment of infectious diseases; diagnostic reagents used in the fields of biological, genetic engineering and pharmaceutical research; diagnostic reagents comprising exosome used in the fields of biological, genetic engineering and pharmaceutical research; pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, extracellular vesicle (EV)-based nucleic acid therapeutics for the prevention and treatment of infections or infectious diseases; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies, namely, mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; all of the foregoing excluding such goods in the fields of digestive diseases, gastrointestinal diseases, constipation, gut health, weight loss, appetite suppressants, dietetic preparations, nutrition, and enzymes
• DS0000: "THERAPEUTICS"
• GS0421: Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific research and analysis services in the field of pharmaceuticals; biological research; clinical research in the field of transformational therapeutics; providing medical research and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; all of the foregoing excluding such services in the fields of digestive diseases, gastrointestinal diseases, constipation, gut health, weight loss, appetite suppressants, dietetic preparations, nutrition, and enzymes

Case File Event Statements

• 1/7/2023 - 2 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 12/30/2022 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC

• 1/3/2023 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/11/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 9/23/2023 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/24/2023 - a year ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 10/4/2023 - a year ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 11/27/2023 - a year ago

  10 - CORRECTION CREATED FOR IB Type: CRCR

• 4/4/2024 - 10 months ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/5/2023 - a year ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 10/31/2023 - a year ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 11/27/2023 - a year ago

  11 - CORRECTION SENT TO IB Type: CRSN

• 4/4/2024 - 10 months ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/6/2024 - 10 months ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/14/2024 - 9 months ago

  15 - ASSIGNED TO EXAMINER Type: DOCK

• 6/20/2024 - 7 months ago

  19 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 12/20/2024 - a month ago

  22 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT

• 6/7/2024 - 8 months ago

  16 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 6/20/2024 - 7 months ago

  17 - FINAL REFUSAL WRITTEN Type: CNFR

• 6/20/2024 - 7 months ago

  18 - FINAL REFUSAL E-MAILED Type: GNFR

• 11/25/2024 - 2 months ago

  20 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 12/20/2024 - a month ago

  24 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 12/20/2024 - a month ago

  21 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF

• 12/20/2024 - a month ago

  23 - EX PARTE APPEAL-INSTITUTED Type: EXPI

• 12/23/2024 - a month ago

  26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/23/2024 - a month ago

  27 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/23/2024 - a month ago

  25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/26/2024 - a month ago

  28 - EXPARTE APPEAL TERMINATED Type: EXPT

• 1/15/2025 - a month ago

  29 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/21/2025 - 24 days ago

  30 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/30/2025 - 15 days ago

  32 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 1/21/2025 - 24 days ago

  31 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB